Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerCancer Microenvironment and Endoplasmic Reticulum Stress ResponseDifferential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteinsAn Endogenous Electron Spin Resonance (ESR) signal discriminates nevi from melanomas in human specimens: a step forward in its diagnostic application.Identification of serum regression signs in infantile hemangioma.RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo.Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinomaPhase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma.Mammary tumors that become independent of the type I insulin-like growth factor receptor express elevated levels of platelet-derived growth factor receptors.The interconnectedness of cancer cell signaling.Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis.Ion channels expression and function are strongly modified in solid tumors and vascular malformationsThe War on Cancer rages on.PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach.Receptor tyrosine kinases and their activation in melanoma.Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy.The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.Intracellular targets of RGDS peptide in melanoma cells.Detection of centrosome aberrations in disease-unrelated cells from patients with tumor treated with tyrosine kinase inhibitors.Platelet-derived growth factor and platelet-derived growth factor receptor-α expression in the normal human thymus and thymoma.Antiangiogenic effects of recombinant human endostatin in lung cancers.Pathway-based dissection of the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrich.
P2860
Q24628746-21550F83-99E8-44F1-BD87-3B244966E3F4Q26778533-B1DC7936-ECC0-41F6-A1CA-39E12096B0AEQ28488743-6619FBA9-422C-4BEB-8DB9-26FC154CB115Q31106767-1F684E2A-D0F3-4EB4-AE43-BB76E21A97A2Q31153322-BB90C62B-06E6-4BF0-A568-5BA4B71AC802Q34044872-CC566A71-2A93-44D4-AD8F-EAC87BABAEB2Q34786434-930674AD-343A-42FA-9CF3-B2E1958EEA14Q35633850-A140A9D7-854E-44FD-8617-F7DF8223E579Q35661710-DA359BB9-07F1-4601-A896-4EB581CBF288Q35669733-17765C41-F4FE-4032-AEAF-E1ADB9D5CAF2Q35955155-7B59BD9D-A336-4936-BB16-55D6D33428A1Q37311346-7BC33E86-9244-49BF-8317-0A3B64D4FC82Q37478602-2556C2FC-8806-4D6C-978B-832547AC6CBAQ37718362-2738FBBA-FDE4-4567-A9A4-648989CD7CCBQ37841746-D5F36D9E-7C8B-4A9B-9F34-BB34597525C1Q38974204-5036C50C-F9CF-4ACD-B509-FEDFDF02D6E9Q39647893-7CCEB665-18BE-4E00-B614-710981EDA58AQ39711810-BA07C7D3-65A6-4053-A217-6CCFC47E66DCQ43090526-C5314544-5B24-4053-9853-CBB6277FA066Q46250502-090A7603-B9BC-48A7-87DE-2C420F4489C1Q47370386-E604FCF9-CF9F-4984-BB1E-F05DC178C83EQ55080794-640C2A4C-36F2-44BA-8C28-112F547E3972
P2860
Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Platelet-derived growth factor ...... a growth in vitro and in vivo.
@en
Platelet-derived growth factor ...... a growth in vitro and in vivo.
@nl
type
label
Platelet-derived growth factor ...... a growth in vitro and in vivo.
@en
Platelet-derived growth factor ...... a growth in vitro and in vivo.
@nl
prefLabel
Platelet-derived growth factor ...... a growth in vitro and in vivo.
@en
Platelet-derived growth factor ...... a growth in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Platelet-derived growth factor ...... a growth in vitro and in vivo.
@en
P2093
Alessandra Magenta
Angelo M Facchiano
Antonio Facchiano
Debora Faraone
Eleonora Cesareo
Francesco Facchiano
Gabriele Toietta
Maria Simona Aguzzi
Maurizio C Capogrossi
Silvia Truffa
P2860
P304
P356
10.1593/NEO.09408
P577
2009-08-01T00:00:00Z